ORMP · Oramed Pharmaceuticals Inc. · Proposed Sales
$4.38
-0.17 (-3.74%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$196.76M
Shares
41.60M
Volume · Oct 6
96.23K
Avg daily vol (3M)
195.35K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-10-01 | Joshua Hexter | Officer | 30,000 | 2026-10-01 | Oppenheimer & Co. Inc. |
| 2026-10-01 | Avi Gabay | Officer | 20,000 | 2026-10-01 | Oppenheimer & Co. Inc. |
| 2026-07-01 | Gabay Avraham | Officer | 93,360 | 2026-07-01 | Oppenheimer & Co. Inc. |
| 2026-07-01 | Hexter Joshua | Officer | 137,000 | 2026-07-01 | Oppenheimer & Co. Inc. |
Showing 1–4 of 4 filings